Literature DB >> 26090973

Risk Factors for Hip Displacement in Children With Cerebral Palsy: Systematic Review.

Blazej Pruszczynski1, Julieanne Sees, Freeman Miller.   

Abstract

BACKGROUND: When hip displacement in children with cerebral palsy (CP) is identified early, treatment is more successful. The standard test is a radiograph of the pelvis measuring the migration index (MI). Our study aims to review published literature of the natural history of hip dislocation among children with CP and to define related risk factors to develop screening criteria for early recognition.
METHODS: The review included 10 studies with sample sizes greater than 20 children with CP below18 years who had hips with no surgical intervention or dislocation at initial presentation, minimum 2-year follow-up, and recorded MI, pattern, and Gross Motor Function Classification System (GMFCS) level.
RESULTS: On the basis of this review, we suggest screening with 1 radiograph for GMFCS I and II, or, if MI>30%, an annual radiograph between ages 2 and 8 years, followed by a radiograph every 2 years until the age of 18 years. For GMFCS III, IV, and V, we recommend an annual radiograph if MI<30% or 1 every 6 months if MI>30% between ages 2 and 8 years, followed by radiograph every 2 years until the age of 18 years.
CONCLUSIONS: Applying a practical surveillance program for children with CP can prevent hip dislocation, provide early treatment, and ultimately lead to consistently better outcomes than those of neglected hip dislocations. The GMFCS level has a strong impact on subluxation risk and that the risk continues to the end of growth. LEVEL OF EVIDENCE: Level III-systematic review.

Entities:  

Mesh:

Year:  2016        PMID: 26090973     DOI: 10.1097/BPO.0000000000000577

Source DB:  PubMed          Journal:  J Pediatr Orthop        ISSN: 0271-6798            Impact factor:   2.324


  9 in total

1.  Outcome of bilateral hip reconstruction in unilateral hip subluxation in cerebral palsy: Comparison to unilateral hip reconstruction.

Authors:  N Kamisan; V Thamkunanon
Journal:  J Orthop       Date:  2020-07-08

2.  The Impact of Spinal Fusion on Hip Displacement in Cerebral Palsy.

Authors:  Mutlu Cobanoglu; Brian Po-Jung Chen; Lucio Perotti; Kenneth Rogers; Freeman Miller
Journal:  Indian J Orthop       Date:  2020-10-09       Impact factor: 1.251

Review 3.  Hip Displacement in Cerebral Palsy: The Role of Surveillance.

Authors:  Alaric Aroojis; Nihit Mantri; Ashok N Johari
Journal:  Indian J Orthop       Date:  2020-06-11       Impact factor: 1.251

4.  Orthopedic surgery in cerebral palsy: Instructional course lecture.

Authors:  Deepak Sharan
Journal:  Indian J Orthop       Date:  2017 May-Jun       Impact factor: 1.251

5.  Parents and Caregivers Satisfaction After Palliative Treatment of Spastic Hip Dislocation in Cerebral Palsy.

Authors:  Aleksander Koch; Joanna Krasny; Magdalena Dziurda; Magdalena Ratajczyk; Marek Jozwiak
Journal:  Front Neurol       Date:  2021-03-18       Impact factor: 4.003

6.  Risk factors for hip displacement in cerebral palsy: A population-based study of 121 nonambulatory children.

Authors:  Terje Terjesen; Joachim Horn
Journal:  J Child Orthop       Date:  2022-08-02       Impact factor: 1.917

7.  Non-attendance at outpatient clinic appointments by children with cerebral palsy.

Authors:  Simon P Paget; Sarah McIntyre; Shona Goldsmith; Katarina Ostojic; Jane Shrapnel; Francisco Schneuer; Mary-Clare Waugh; Maria Kyriagis; Natasha Nassar
Journal:  Dev Med Child Neurol       Date:  2022-03-04       Impact factor: 4.864

8.  Long-term effect of botulinum toxin A on the hip and spine in cerebral palsy: A national retrospective cohort study in Taiwan.

Authors:  Ching-Yueh Lin; Chi-Hsiang Chung; Dennis J Matthews; Heng-Yi Chu; Liang-Cheng Chen; Sung-Sen Yang; Wu-Chien Chien
Journal:  PLoS One       Date:  2021-07-22       Impact factor: 3.240

9.  Hip displacement in children with cerebral palsy in Scotland: a total population study.

Authors:  K E Bugler; M S Gaston; J E Robb
Journal:  J Child Orthop       Date:  2018-12-01       Impact factor: 1.548

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.